DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Klonoff DC, Buse JB, Nielsen LL. et al.
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic
biomarkers in patients with type 2 diabetes treated for at least 3 years.
Curr Med Res Opin 2008;
24: 275-286
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.